Executive Function Dysregulation in Addiction

Overview

The preoccupation/anticipation (craving) stage of addiction is defined by two concurrent and seemingly paradoxical processes: (1) hyperactivation of craving circuits (Go system) and (2) hypoactivation of inhibitory control circuits (Stop system). The result is impaired decision making, self-regulation, and response inhibition — which locks individuals in compulsive drug seeking despite awareness of consequences.

Core Circuitry

Prefrontal Cortex (PFC)

The PFC occupies a critical position:

Sends glutamatergic projections directly to VTA (excitatory control over dopamine firing) and to NAc and dorsal striatum (modulating both direct D1 and indirect D2 pathways).
Subdivisions with distinct roles:
- Prelimbic PFC: Projects to NAc; mediates drug-induced and cue-induced reinstatement.
- Infralimbic PFC: Projects to NAc shell; involved in craving incubation via calcium-permeable AMPA receptor recruitment.
- Dorsolateral PFC (DLPFC): Working memory, cognitive control; decreased activity in addiction.
- Anterior cingulate cortex (ACC): Conflict monitoring, response inhibition; activated during craving; decreased at baseline in addiction.
- Orbitofrontal cortex (OFC): Reward value assessment; dysregulated baseline function with spikes during acute craving.

The Go / Stop Framework

Go system (basal ganglia-mediated): Drives craving and compulsive habits. Connectivity between medial PFC/ACC and ventral striatum, and between insula and dorsal striatum, is increased with cocaine dependence.
Stop system (ventromedial PFC-mediated): Inhibits craving and suppresses responses to negative emotional signals. Analogous to ventromedial PFC inhibition of central amygdala in PTSD; successful craving inhibition in cocaine abusers is associated with right medial OFC inhibition and right inferior frontal cortex activation.

Glutamate Dysregulation

PFC glutamatergic projections to NAc are a key substrate of cue-induced and drug-induced reinstatement.
Craving-stage activity in PFC generates strong glutamatergic drive on NAc — hypothesised to underlie craving-like responses.
AMPA receptors:
- Infralimbic PFC → NAc shell: calcium-permeable AMPA receptors recruited during craving incubation.
- Prelimbic PFC → NAc core: non-calcium-permeable AMPA receptors.
- mGluR1 blockade in NAc inhibits both cue-induced and cocaine-primed reinstatement — potential therapeutic target. (Animal model; not yet in clinical use.)
Protracted abstinence (especially in alcohol dependence) involves overactive glutamatergic and CRF systems.

D2 Receptor Deficits and PFC Hypofunction

Striatal D2 receptor availability is substantially reduced in addiction; persists months post-detoxification.
Low D2 availability correlates with:
- Decreased baseline glucose metabolism in DLPFC, ACC, and medial OFC.
- Impulsivity in methamphetamine abusers.
- Compulsive cocaine self-administration in rodents.
Mechanism: tonic dopamine stimulation of D2 (inhibitory) receptors maintains prefrontal function; D2 deficits remove this support → PFC hypometabolism.

Insula and Interoception

The insula integrates autonomic/visceral information with emotion and motivation, generating conscious awareness of urges.
Activated during craving (likely via CRF); differential activation is hypothesised as a relapse biomarker.
Key finding: Tobacco smokers with insula damage stopped smoking easily with no craving or relapse; smokers with non-insular lesions did not. (Lesion study; N small but striking.)
Insula reactivity to drug cues is a candidate neuroimaging biomarker for relapse prediction.

Executive Function Impairments in Humans

Alcoholics show impairments in: spatial working memory, decision making, behavioural inhibition.
Syndrome described by Volkow et al.: excessive salience to drug-paired cues + decreased responsiveness to non-drug rewards + decreased ability to inhibit maladaptive behaviour.
Executive function deficits are linked to reduced efficacy of behavioural treatments.

mTORC1 and Memory Reconsolidation

mTORC1 (mechanistic target of rapamycin complex 1) is activated in hippocampus, frontal cortex, NAc, and amygdala by drug/alcohol cues.
Systemic mTORC1 blockade disrupts reconsolidation of cocaine memories.
Amygdala mTORC1 blockade disrupts reconsolidation of alcohol memories.
These findings identify mTORC1 as a potential target for disrupting relapse-relevant memory traces. (Animal models; clinical application not established.)

Established vs. Hypothesized

Claim	Status
D2 deficits in striatum correlate with PFC hypofunction and impulsivity	Established: imaging correlations, animal data
Prelimbic PFC→NAc glutamate circuit mediates drug-induced reinstatement	Established: animal models
Insula damage eliminates craving and relapse in smokers	Established: lesion study in humans
AMPA receptor recruitment underlies craving incubation	Established: animal models
mTORC1 blockade disrupts drug memory reconsolidation	Established: animal models; not yet clinical
mGluR1 in NAc as therapeutic target	Hypothesis: animal model data; no clinical trials